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Abstract
Aseptic lymphocyte-dominated vasculitis-associated lesion (ALVAL) has been used to describe the histological lesion
associated with metal-on-metal (M-M) bearings. We tested the hypothesis that the lymphoid aggregates, associated with
ALVAL lesions resemble tertiary lymphoid organs (TLOs). Histopathological changes were examined in the periprosthetic
tissue of 62 M-M hip replacements requiring revision surgery, with particular emphasis on the characteristics and pattern of
the lymphocytic infiltrate. Immunofluorescence and immunohistochemistry were used to study the classical features of
TLOs in cases where large organized lymphoid follicles were present. Synchrotron X-ray fluorescence (XRF) measurements
were undertaken to detect localisation of implant derived ions/particles within the samples. Based on type of lymphocytic
infiltrates, three different categories were recognised; diffuse aggregates (51%), T cell aggregates (20%), and organised
lymphoid aggregates (29%). Further investigation of tissues with organised lymphoid aggregates showed that these tissues
recapitulate many of the features of TLOs with T cells and B cells organised into discrete areas, the presence of follicular
dendritic cells, acquisition of high endothelial venule like phenotype by blood vessels, expression of lymphoid chemokines
and the presence of plasma cells. Co-localisation of implant-derived metals with lymphoid aggregates was observed. These
findings suggest that in addition to the well described general foreign body reaction mediated by macrophages and a T cell
mediated type IV hypersensitivity response, an under-recognized immunological reaction to metal wear debris involving B
cells and the formation of tertiary lymphoid organs occurs in a distinct subset of patients with M-M implants.
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Introduction
Total hip replacement is the most successful surgical procedure
for the long-term alleviation of pain and disability in patients with
hip arthritis [1]. The cellular reaction to wear particles in the tissue
around total joint replacements has long been considered to be a
significant contributor to aseptic implant loosening [2]. Metal-on-
polyethylene (M-P) bearing surfaces have historically been the
standard articulation. However these bearings predominantly
generate polyethylene wear debris, the cellular reaction to which
gives rise to local bone loss [2]. High-carbon, cobalt-chromium-
molybdenum alloys have returned to prominence with hip
resurfacing surgery and have increasingly been used over the last
decade [3,4,5].
Recently, there has been concern expressed over the biological
responses to metal wear debris occurring in some individuals with
Metal-on-metal (M-M) hips. A number of terms have been used in
the literature to describe both the clinical and pathological entities
associated with M-M bearings [2,6,7,8,9,10]. However, there is no
clear consensus defining the boundaries of each of these terms
[11]. Adverse reaction to metal debris (ARMD) is an umbrella
term that encompasses a spectrum of findings and includes
metallosis, pseudotumour, ALVAL (aseptic lymphocyte-dominat-
ed vasculitis-associated lesion), and macroscopic tissue necrosis [9].
Metallosis is the macroscopic staining of the soft-tissues and is
associated with abnormal wear [11]. Pseudotumours are non-
neoplastic, non-infective, solid or semi-liquid soft-tissue peripros-
thetic masses associated with M-M hip bearings which can
progress to soft-tissue destruction with subsequent poor clinical
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outcomes [8,12,13,14]. The entity ALVAL was introduced to
describe a specific adverse histological reaction to metal wear
debris [7]. ALVAL is characterised by tissue necrosis, fibrin,
perivascular lymphocytes, lymphoid aggregates containing B and
T cells, and plasma cells [7].
While it has been recognised that sensitisation occurs in some
individuals receiving metal implants, with a T cell mediated type
IV hypersensitivity response occurring in the local soft tissues [15],
controversy exists regarding whether this hypersensitivity is indeed
the dominant biological reaction responsible [16]. In addition, it is
not yet understood how the recently-described presence of both B
and T cells in the periprosthetic tissues of failed M-M bearings fits
with the clinical and histopathological picture
[7,8,14,15,17,18,19,20,21,22].
The B and T cell-containing aggregates seen in ALVAL, bear a
remarkable resemblance to tertiary lymphoid organs (TLOs)
described in tissues of several chronic inflammatory diseases [23]
such as the joints of rheumatoid arthritis (RA) [24,25,26], the
salivary glands of Sjogren’s syndrome [27,28], and the thyroid of
Hashimoto’s thyroiditis [29]. The clinical relevance of these
structures is debated with evidence that associates lymphoid
follicles with more aggressive disease and a worse clinical outcome
[26,30]. Functionality of TLOs has been recognized in terms of
local expression of activation-induced cytidinedeaminase (AID),
the enzyme responsible for class-switch recombination (CSR) and
somatic hypermutation (SHM) and differentiation of plasma cells,
establishing the critical link between TLO formation and humoral
immunity [31,32,33]. The question therefore arises as to whether
the B and T cell aggregates found in periprosthetic tissues of M-M
hip arthroplasties are in fact lymphoid follicles of the type
recognised as TLO’s and whether this histological presentation is
associated with a defined disease process and clinical prognosis.
Here we provide the first description of ALVAL as TLO, by
investigating the cellular and molecular features typical of tertiary
lymphoid organs in these specific periprosthetic tissues.
Materials and Methods
Review of clinical material
Local ethics committee approval was obtained for this study
from North West 5 Centre for Research Ethics Committee (REC
Reference 09/H1010/75) and the NRES Committee South West,
Bristol REC centre (REC Reference 12/SW/0088). All patients
gave written consent and the ethics committees approved the
consent procedure. Sixty-two cases of M-M hip resurfacings and
total hip replacements undergoing revision surgery at a single
specialist arthroplasty centre between 1998 and 2012 were
included. Cases were identified from the clinical and histopathol-
ogy databases of the hospital. All revisions were performed for
suspected adverse reactions to metal debris. Cases were excluded if
there was microbiological or histological evidence of infection, or if
the index procedure was performed for rheumatoid arthritis. The
archival paraffin embedded sections containing periprosthetic
tissue taken at the time of revision surgery were anonymised by the
allocation of a study number. Two histopathologists (P.A.R and
V.P.S), blinded to the clinical details and the cellular pathology
diagnostic reports, reviewed all sections.
Characterisation of histopathological appearances
Five mm formalin fixed paraffin embedded tissue sections
underwent routine staining with haematoxylin-eosin (H&E) to
determine the presence of individual histological features found in
relation to failed prosthetic joints (2). Lymphocytic and macro-
phage infiltrates were assessed and on the basis of their distribution
classed as either diffuse, perivascular or focal aggregates. Further
characterization of the aggregates was achieved by staining
sequential sections with pan T (CD3) and pan B (CD20) cell
markers by immunohistochemistry. Briefly, sections were depar-
affinised and rehydrated through xylene and graded ethanol
solutions. After washing in running water, antigen retrieval was
carried out by incubating the sections in epitope retrieval solution
at pH 8 (Novocastra RE7116) for 16 hours at 68uC. Following
incubation with primary antibody for 1 hour at room temperature
at optimised dilutions (CD3, 1:50; CD20, 1:600), the brown colour
reaction with diaminobenzidine (DAB) was developed using
ChemMateEnVision detection kit (Dako) according to the
manufacturer’s instructions. Tonsil and reactive lymph node were
used as positive controls.
Characterization of tertiary lymphoid tissue
For immunofluorescence and double immunohistochemistry,
formalin fixed paraffin embedded 5 mm tissue sections were
treated with W-CAP TEC buffer, pH 8.0 (Bio Optica, Milan,
Italy) for 40 min at 98uC for deparaffinisation and antigen
retrieval.
Immunofluorescence
For triple staining with immunofluorescence, the sections were
washed and blocked with 10% FCS in PBS for 30 min and
incubated with primary antibodies overnight at 4uC. To avoid
cross reactivity, primary antibodies from different species or
different mouse sub-classes were used in combination. After three
washes in PBS, the sections were incubated with the appropriate
secondary antibodies for one hour at room temperature. The
secondary antibody cocktail also contained Hoechst dye for
nuclear staining. After the final three washes with PBS, slides were
mounted in 2.4% w/v 1,4-diazabicyclo (2,2,2) octane (Aldrich,
Gillingham, England) in 90% v/v glycerol (Fisons Scientific,
Loughborough, UK) in PBS (pH, 8.6) and analysed by confocal
microscopy (LSM 510; Carl Zeiss Ltd, Cambridge, England).
Immunohistochemistry
Single or double antigen labelling immunohistochemistry (IHC)
was performed to visualise CXCL13 and CCL21. Briefly, after
dewaxing and antigen retrieval, the sections were incubated with
BLOXALL (Vector laboratories) for 10 min to block any
endogenous peroxidase and alkaline phosphatase activity. After
washing with TBS pH 7.6, the sections were incubated with
primary antibodies for 1 hour at room temperature and then
washed. Sections were incubated for 45 min at room temperature
with either donkey anti-sheep IgG biotinylated antibody and anti-
mouse IgG-HRP (Mouse ImmPRESS kit, Vector Laboratories), or
with donkey anti-sheep IgG biotinylated antibody and anti-rabbit
IgG-HRP (Rabbit ImmPRESS kit, Vector Laboratories). This was
followed by incubation with a preformed avidin and biotinylated
alkaline phosphatase macromolecular complex (VECTASTAINH
ABC-AP kit, Vector Laboratories). After the final wash in TBS
pH 7.6 brown colour was developed using ImmPACT DAB
Peroxidase Substrate (Vector laboratories) and subsequently red
colour was developed using vector red alkaline phosphatase
substrate kit (Vector laboratories). Finally the sections were
counterstained with haematoxylin and mounted in glycergel
(Dako, Cambridge). Images were acquired using Leica DM6000
photomicroscope (Leica Microsystems, UK) and analysed with
QCapture Pro software.
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PLOS ONE | www.plosone.org 2 May 2013 | Volume 8 | Issue 5 | e63470
Antibodies
The primary and secondary reagents used for immunofluores-
cence and immunohistochemistry are: Primary antibodies: CD3
(polyclonal rabbit) Dako; CD3 (clone PS1) Novocastra; CD20
(clone L-26) Dako; GP38 (clone D2-40) Serotec; CD138 (clone B-
A38) Serotec; CD21 (clone 2G9) Dako; PNAd (clone MECA-79)
BD Pharmigen; CXCL13 (polyclonal goat AF801) R&D systems;
CCL21 (polyclonal goat AF366) R&D systems; Baff (polyclonal
rabbit) Chemicon; April (clone April-2) Enzo life sciences. Secondary
antibodies: Anti-mouse IgG1 FITC, Southern Biotechnologies;
Anti-fluorescein Alexa 488, Invitrogen; Anti-mouse IgG2b
TRITC, Southern Biotechnologies; Anti-rat IgM Alexa 649,
Invitrogen; Anti-rabbit IgG Cy5, Jackson ImmunoResearch; Anti-
rabbit IgG TRITC, Jackson ImmunoResearch; Anti-rabbit IgG
TRITC, Jackson ImmunoResearch; Anti-sheep biotin, The
Binding Site.
Confocal microscopy
Images were acquired on LSM 510-UV confocal microscope
and analysed by the LSM510 Image Examiner software. For
quantification of T and B cells the relative percentage of CD3 and
CD20 cells were determined by counting the number of positive
pixels/area of aggregate for both CD3 and CD20 channels.
Statistical analysis
Graphpad prism5 was used for quantification and statistical
analysis, and the Mann-Whitney test was performed to determine
differences between subgroups. A p-value of,0.05 was considered
to be statistically significant.
Synchrotron X-ray fluorescence measurements
Frozen sections (4–6 mm thickness) were cut using a cryotome
from tissue that had been snap frozen in liquid nitrogen after
surgical retrieval in order to maintain the distribution and
speciation of implant-derived metallic elements. A tungsten
carbide knife was used to prevent spurious contamination with
cobalt (Co) and chromium (Cr). Preliminary histological investi-
gations of the tissue block confirmed the presence of TLO-like
structures. Alternating sections were reserved for haematoxylin
and eosin staining; elemental mapping using synchrotron X-ray
fluorescence (XRF) or immunofluorescence. Sections for synchro-
tron XRF measurements were mounted on ultra-pure fused silica
plates possessing trace concentrations of Co and Cr at ,10 ppb
(Spectrosil 2000, Heraeus Quarzglas GmbH & Co., Hanau,
Germany). To comply with experimental facility protocols for
unfixed human tissue, the sections were covered with a 4 mm
Ultralene film (SPEXSamplePrep., NJ, USA) which was secured at
the periphery of the glass slide with epoxy resin. Synchrotron
micro-focus XRF measurements were undertaken using a 4-
element Si drifts detector on the I18-Beamline at the Diamond
Light Source (Oxfordshire, UK) using an incident energy of
10 keV. Tissue sections were initially mapped using a 50 mm
resolution to identify areas of interest. Subsequently, the incident
beam was focused to give a spot size 5 mm (height) by 3.4 mm
(width) and the sample was mounted at a 45u angle to the incident
beam, thus resulting in a beam footprint of 565 mm and providing
a resolution at a length scale similar to that of individual cells. Data
was calibrated using the incident, Ar and Fe energy peaks prior to
background correction and peak fitting for Co and Cr using
PyMCA software [34]. Elemental maps for Co and Cr of regions
consistent in appearance with TLO structures were correlated
with the underlying histology and immunohistochemistry using the
adjacent sections stained either with H&E or for immunofluores-
cence as references. XRF maps were overlaid on confocal
microscopy images enabling statistical comparison of the fitted
Co and Cr fluorescence values between regions with T and B cell
infiltrates; with disorganised immune cell infiltrates and with the
acellular background levels. One way analyses of variance
(ANOVA) and post-hoc Tukey tests were performed at a 95%
significance level.
Results
Histopathological review of periprosthetic tissues from
revised M-M hips
Histological examination of 62 periprosthetic tissue samples
from M-M hip bearings demonstrated macrophages with variable
amounts of intracellular metal wear debris in 55 cases (89%), with
the macrophages present in the remaining 7 cases (11%)
containing no apparent particles. Lymphocyte populations were
present in 51 cases (82%) with 11 samples (18%) lacking any
significant lymphocytic infiltrate.
The distribution of lymphocyte populations determined from
H&E sections and immunohistochemistry enabled subdivision of
the 51 cases with lymphocytic infiltrate into three distinct groups,
namely: a) diffuse lymphocyte infiltration with no aggregates
(group 1); b) lymphocyte aggregates containing predominately T
cells (group 2); c) lymphocyte aggregates containing T and B cells
(group 3). A diffuse T cell infiltrate was seen in 26 cases (51%) in
which there were no aggregates (Figure 1A, B), T cell aggregates
were seen in 10 cases (20%) (Figure 1C, D) and organized T and B
Figure 1. Histopathological review of periprosthetic tissues
from hip joint M-M revision surgery. Histopathological appear-
ances in formalin fixed sections showing group 1: diffuse lymphocyte
infiltrate (A), group 2: T cell aggregate (C), and group 3: organised
lymphoid aggregate with central follicular area (E). Immunohistochem-
istry with CD3 shows diffuse (B), T cells in an aggregate (D) and T cells
mixed with B cells (not stained) in a follicular type of aggregate (F).
Images taken at 10X magnification.
doi:10.1371/journal.pone.0063470.g001
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cell aggregates, with appearances of TLOs were present in 15
cases (29%) (Figure 1E, F).
T/B cell segregation, formation of FDC networks and
High Endothelial Venules (HEVs)
Periprosthetic tissues from all 15 patients belonging to group 3
were further characterised for hallmark features of tertiary
lymphoid tissue including segregation of T cells and B cells into
discrete areas, presence of follicular dendritic cells (FDCs)
indicative of a germinal centre-like reaction and acquisition of
high endothelial venule (HEV)-like phenotype by blood vessels. In
order to assess the compartmentalisation of T and B cells into
discrete areas along with the formation of FDC network,
sequential sections were stained by triple immunofluorescence
using markers for T cells (anti-CD3), B cells (anti-CD20), and the
lymphoid stromal cell marker, podoplanin (Figure 2). All 15
samples showed aggregates of CD3+ T cells distributed loosely
surrounding centrally placed CD20+ B cells (Figure 2A). In a large
percentage of the foci (55%), a histologically recognisable germinal
centre could be identified in the B cell-rich zone. Intense
podoplanin staining was consistently detected in this area
assuming the typical reticular pattern usually associated with an
FDC network (Figure 2A, B) as well as on lymphatic vessels outside
the germinal center. FDC identity was further confirmed by
double immunofluorescence using antibody to podoplanin as well
as CD21 (marker for FDCs) that showed co-localization between
the two markers (Figure 2b).
Quantification of B and T cells, the percentage of segregation in
T/B cell discrete areas and the presence of FDC networks were
performed on a total of 65 lymphoid aggregates present in the 15
samples. On average, the inflammatory foci contained a larger
percentage of T cells (60%) as compared to B cells (40%) with
scarce variability among aggregates from the same or different
samples (P,0.001). Only 40% of all the lymphoid aggregates were
found to be segregated in discrete T/B cell areas. No correlation
was found between the percentage of B cells infiltrating the
samples and the degree of T/B cell segregation. As expected,
FDCs were detected in a high percentage (range 60-70%) of
segregated aggregates.
The activated blood endothelial cells of secondary and tertiary
lymphoid organs acquire a HEV-like phenotype by expressing
adhesion molecules and the peripheral node adresin (PNAd),
which aids the recruitment of circulating T and B cells into these
tissues [35]. Using antibody to PNAd (MECA-79), the presence of
HEVs was detected in the tissues of all 15 patients from group 3.
HEVs were found in the T cell areas, at the periphery of the
aggregates (Figure 3) or in the inter-follicular area. PNAd+ HEVs
were detected in all samples containing large organised follicles.
Expression of the constitutive chemokines CXCL13 and
CCL21
The expression of the lymphoid homing chemokines, CCL21
and CXCL13, has been shown to be critical for recruitment of T
and B cells and their compartmentalisation into functional zones
during development of lymphoid organs and in tertiary lymphoid
organ formation [24,27,28,36,37]. The expression of the chemo-
kines CCL21 and CXCL13 in organised lymphoid aggregates was
studied by single immunohistochemistry (Figure 4A, D). Double
immunohistochemistry was also used to study the expression of
CXCL13 in association with either CD20+ B cells or the CD21+
FDC network and CCL21 expression in association with PNAd+
HEVs (Figure 4B, b, E, F). CXCL13 expression was mainly
detected in the B cell rich area and in association with the FDC
network within the germinal centre like structures (Figure 4E, F).
Scarce expression of CCL21 could be detected in the T cell areas
of large highly organised lymphoid aggregates (Figure 4A). Little
CCL21 expression was observed in association with PNAd+ HEVs
(Figure 4B, inset b), unlike that classically observed in secondary
lymphoid organs. Positive CCL21 staining was demonstrated on
tonsil (Figure 4C).
Expression of B cell survival and proliferation factors, Baff
and April
Baff (B cell activating factor) and April (A proliferation inducing
ligand) are members of the TNF superfamily that have been
shown to play a crucial role in survival, activation and proliferation
of B cells as well as the maintenance of the plasma cell
compartment in secondary lymphoid organs [38,39]. Since the
lymphoid aggregates of group 3 showed a high percentage of B
cells (as compared to the other groups), we studied the expression
of Baff and April in these tissues by immunofluorescence.
Expression of Baff was mainly detected within the germinal centre
in association with FDC networks. April expression showed a
diffuse distribution within the tissue with greater intensity observed
inside the lymphoid aggregates (Figure 5A, inset a). Abundant
plasma cells labelled positively for syndecan (CD138) were
confirmed as present either at the periphery of the aggregates or
dispersed within the surrounding tissue (Figure 5B), suggesting a
Figure 2. Lymphoid follicles resembling ectopic tertiary lymphoid organs occurs in a distinct subset of patients with lymphoid-like
aggregates. A) Immunofluorescence (IF) from tissues of M-M implants with lymphoid follicles show central B cell rich area (red) surrounded by T
cells (blue) and reticular pattern of podoplanin expression in the B cell area (green). (B, b). IF images showing co-localisation of CD21+ FDC network
(red) with podoplanin (green). FDC network stained with CD21 and podoplanin are largely excluded from T cell area (blue).
doi:10.1371/journal.pone.0063470.g002
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functional role of the foci in the process of B cell affinity
maturation and local plasma cell differentiation.
Co-localisation of implant derived metal ions with TLO
structures
In order to explore whether the formation of TLO’s was
associated with the presence of implant metal derivatives in
synovial tissue, we performed synchrotron XRF measurements for
cobalt and chromium in synovial tissue samples from M-M hip
replacements where lymphoid aggregates occurred. Micro-focus
XRF measurements at a 5 mm resolution allowed visualisation of
Co and Cr distributions at a similar length-scale to individual cells.
Superimposition of synchrotron XRF measurements with the
underlying cellular content demonstrated a clear co-localisation
(significantly increased regional concentrations) of the principle M-
M hip implant metallic elements, Co and Cr, with regions of dense
T and B cell infiltration (Figure 6A–E). One-way ANOVAs and
post-hoc Tukey tests demonstrated that the mean Co and Cr
fluorescence values were significantly increased in all areas of the
synovial tissue when compared with background levels (P,0.001).
However, both Co and Cr were encountered in significantly
elevated levels in regions of T and B cell infiltration when
compared to non-infiltrated regions of the tissue (P,0.001). Cr in
particular appeared concentrated in such TLO regions demon-
strating a 2.9 fold increase in fluorescence values compared with a
2.0 fold increase in the Co signal.
Figure 3. Presence of HEVs in ectopic lymphoid follicles. Paraffin sections of periprosthetic tissues having large lymphoid-like aggregates
were stained with marker for B cell, CD20 (pink) and marker for HEVs, PNAd (cyan). Shown are representative images from the group containing large
lymphoid aggregates. Plump HEVs expressing PNAd were detected in the periphery of lymphoid aggregates, in the T cell area (A, inset a).
doi:10.1371/journal.pone.0063470.g003
Figure 4. Expression of the chemokine CCL21 and CXCL13 in ectopic lymphoid follicles. Photomicrographs of 5 mm thick sections with
immunohistochemical staining of CCL21 and CXCL13 show scarce expression of CCL21 outside the germinal centre, in the T cell area (red in A) and
intense CXCL13 staining in the B cell rich areas (red in D). Double immunohistochemistry show minimal expression of CCL21 (red in B, inset b) with
PNAd+ HEVs (brown in B, inset b). Positive CCL21 expression is detected in control tonsil (red in C). CXCL13 expression (red in E, F) is detected in the
CD20+ B cell-rich areas (brown in E) and CD21+ follicular dendritic cell network (brown in F). Images taken at 106magnification.
doi:10.1371/journal.pone.0063470.g004
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Discussion
Osteolysis and aseptic loosening associated with traditional M-P
implants is mainly considered to be driven by a cell-mediated
reaction, involving a general foreign body reaction by macro-
phages, multinucleate giant cells and T lymphocytes [2]. In
contrast, the presence of lymphoid aggregates containing T and B
cells, plasma cells, and a perivascular lymphocytic infiltrate,
interpreted by some as a vasculitis, are considered to be unique
features of ALVAL associated with M-M bearings [7,9,10,14,40].
In this study, we reviewed and classified the histopathological
changes in periprosthetic tissues of 62 M-M hips revised for
suspected adverse reactions to metal debris. Based on the degree of
organisation of lymphoid aggregates, it was possible to define three
broad but distinct lymphocytic categories; diffuse infiltrates, T cell
aggregates, and organised lymphoid-like aggregates.
Organised lymphoid-like aggregates have been termed tertiary
lymphoid organs (TLOs) because leukocytes are organised within
the foci into structures similar to those observed in secondary
lymphoid organs (SLOs). Features associated with TLOs comprise
centrally placed B cell aggregates with presence of a FDC network,
loosely surrounded by T cells, local expression of lymphoid
chemokines and cytokines as well as presence of plasma cells and
PNAd+ HEVs. This morphological, cellular and molecular
organisation is believed to be pathogenic in mounting a sustained
immune response to persistent antigens in chronic inflammatory
conditions [23].
Figure 5. Expression of the B cell survival factors BAFF and April in ectopic lymphoid follicles and the presence of plasma cells in
ectopic lymphoid follicles. Immunofluorescence images of staining of BAFF (red) and April (green) detected in the CD21+ follicular dendritic cell
network (blue) (A) Paraffin sections of tissues showing organised lymphoid aggregates were also stained with a marker for plasma cells, CD138 (cyan),
and B cells (CD20) (red) by double immunofluorescence (B). Abundant plasma cells were detected at the periphery of the aggregates as well as in the
surrounding tissue. Shown are representative images from the group of cases containing organised lymphoid aggregates.
doi:10.1371/journal.pone.0063470.g005
Figure 6. Co-localisation of implant derived metallic elements, Co and Cr, with TLO structures. Confocal nuclear density map (A) and
overlaid X-ray fluorescence maps for Co (B) and Cr (C) measured at a 50 mm resolution demonstrate a strong co-localisation of Cr with the B and T cell
infiltrate. Scales refer to fluorescence intensity in arbitrary units. (D) is an immunofluorescence image taken from the boxed region in (A) showing B
cells (red) and T cells (blue). Micro-focus X-ray fluorescence maps of the same region (5 mm resolution) demonstrates Co to be more evenly dispersed
(E) with Cr well co-localised with the immune cell infiltrate (F).
doi:10.1371/journal.pone.0063470.g006
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Similar to TLOs found in other chronically inflamed tissues, the
organised lymphoid-like aggregates in periprosthetic tissues of M-
M implants showed some degree of T/B cell segregation with
FDC networks placed in the B cell rich areas indicative of a
germinal centre (GC)-like reaction. The lymphoid aggregates
contained a surprisingly high percentage of B cells (40%). The
presence and abundance of B cells did not correlate with the
degree of segregation in T/B cell areas of the aggregates.
Interestingly, FDC networks were also observed in non-segregated
foci (however they were strictly associated with B cell rich areas),
suggesting that FDC network formation is independent to T/B
segregation in this pathology. This data is in contrast with previous
reports on TLOs in other organs where FDC presence was
detected selectively in segregated foci [28,31].
Specialised stromal cells play an important role in chronic
inflammation and disease persistence [41]. Studies in human and
mouse models have shown that the stroma in ectopic TLOs is
activated and provides the necessary signals for the molecular
events that lead to organisation and maintenance of the infiltrating
immune cells [42]. We detected expression of one such stromal cell
marker, gp38 or podoplanin, in M-M tissues containing lymphoid
aggregates [42,43]. In tissues of M-M implants with organised
lymphoid follicles, podoplanin expression was detected in
lymphatic vessels and within the aggregates in a characteristic
reticular pattern. Surprisingly, unlike SLOs and some other TLOs,
we did not detect podoplanin expression on T-zone fibroblastic
reticular cells (TRCs). Podoplanin staining was, however, detected
in the B cell rich area and showed a reticular pattern of staining
that co-localised with the FDC networks.
FDC networks within GCs play an important role in
augmenting B cell immune responses by trapping and presenting
the antigen and favouring B cell proliferation and differentiation
into affinity-selected B cells and plasma cells [44]. It is tempting to
postulate a similar role for FDC in this context. The origin of FDC
in peripheral tissue is not known. Recently evidence that they
might derive from PDGF-R+ pericytes has been provided [45].
Our data, highlighting the difference in podoplanin expression
between SLOs and TLOs, suggest that there may be different
origins of FDC in secondary and tertiary lymphoid structures.
Formation of tertiary lymphoid organs is classically associated
with modification of vascular endothelium which acquires a plump
morphology and upregulates the expression of adhesion molecules
such as ICAM1, VCAM1, MADCAM1, PNAd. This modification
aids the recruitment of circulating immune cells into the site of
chronic inflammation [35,46]. HEVs are best marked by
expression of peripheral lymph node addressin (PNAd) and are
usually detected within T cell areas and between the follicular
regions of secondary lymphoid organs and TLOs [24,28,46]. This
pattern of PNAd+ HEVs was also found in the periprosthetic
tissues of M-M implants having large organised lymphoid-like
aggregates, further reinforcing the notion that periprosthetic
tissues of some ALVAL cases recapitulate features of TLOs.
We also investigated the expression of lymphoid homing
chemokines, CCL21 and CXCL13, shown to be critical for T
and B cell organisation and maintenance in SLOs and TLOs
[24,27,28,36]. Consistent with other reports [24,27,28], we found
increased expression of CXCL13 within the B cell rich areas and
in co-localisation with the FDC network. While the expression of
CXCL13 has been shown to be a predictive factor for progressive
organisation of lymphoid aggregates, its expression has also been
detected in the absence of full lymphoid organisation indicating an
upstream role for this molecule in TLO formation [25,26,28]. In
contrast to CXCL13, the expression of CCL21 was only scarcely
detected in the T cell areas of some large lymphoid like aggregates
in periprosthetic tissues of M-M implants.
In several autoimmune diseases such as RA and Sjogren’s
syndrome, the formation of fully mature GC displaying FDCs
networks and ectopic lymphoid chemokine expression has been
associated with disease severity and local production of autoan-
tibodies [26,47,48]. In M-M implants, metal ions and nano-sized
particles are generated alongside microscopic wear debris. It is
suggested that ions and nano-particles have the potential to form
complexes with native proteins to generate an immunogenic
hapten-carrier complex. Presentation of the hapten-carrier com-
plex on locally differentiated FDCs, may lead to local breakdown
of self-tolerance, generation of auto-reactive B cells and produc-
tion of auto-antibodies. The observed significant increase in the
regional concentration of Co and Cr with the T and B cell areas
supports this concept. Recent ex-vivo analyses of metal ion
speciation in periprosthetic tissues from failing M-M joints have
suggested Co to be more likely to form peptide associations than
Cr in the periprosthetic environment with the later more likely to
form insoluble inorganic precipitates; however ALVAL cases were
not systematically identified [49]. In this case, the increases in
implant element concentrations in these regions cannot be
accounted for by accumulation in professional phagocytes which
have been extensively demonstrated to be associated with CoCr
implant metal derivatives in synovial tissues [6,9,49]. Our findings
also demonstrate an increase in relative concentration of Cr when
compared with Co within TLO structures which is suggestive of its
importance in ALVAL cases. In further support of this hypothesis,
plasma cells were also found in the periprosthetic tissues with large
organised lymphoid-like aggregates. Accordingly, Baff and April,
key regulators of B cell homeostasis [39], were also found to be
expressed within the aggregates, thus providing the functional
machinery for local plasma cell differentiation and survival.
Nonetheless, further studies are needed to address the origin and
potential antibody repertoire of the plasma cells inhabiting the
reactive tissue in M-M implants.
In conclusion, we have demonstrated for the first time that the
lymphoid aggregates associated with ALVAL in a subset of
patients having M-M hip implants display all the features
associated with TLOs. While the role of T cells and macrophages
has been well established in the reaction to M-M implants, the
presence and importance of B cells has been largely underesti-
mated in the cellular reaction to metal wear debris. In RA, it is
known that B cells not only play a role in autoantibody production
but are also required for macrophage and T cell activation and
production of pro-inflammatory cytokines [50]. The significance
of B cells and TLO formation in M-M implant pathology and its
correlation with disease severity and outcome requires further
evaluation. Similarly, studies to elucidate the association between
tertiary lymphoid organ formation and autoimmunity to metal-
hapten carrier complexes and/or T cell-mediated inflammatory
responses are needed in order to develop novel therapies to
overcome the clinical complications associated with M-M
implants.
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